Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

BACKGROUND: Early in the pandemic it was suggested that pre-existing use of non-steroidal anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with COVID-19. NSAIDs are an important analgesic, particularly in those with rheumatological disease, and are widely availab...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lancet Rheumatol
Autors principals: Drake, Thomas M, Fairfield, Cameron J, Pius, Riinu, Knight, Stephen R, Norman, Lisa, Girvan, Michelle, Hardwick, Hayley E, Docherty, Annemarie B, Thwaites, Ryan S, Openshaw, Peter J M, Baillie, J Kenneth, Harrison, Ewen M, Semple, Malcolm G
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Ltd 2021
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8104907/
https://ncbi.nlm.nih.gov/pubmed/33997800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2665-9913(21)00104-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars